{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:50:35Z","timestamp":1776401435676,"version":"3.51.2"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/MULTI\/00070\/2013"],"award-info":[{"award-number":["UID\/MULTI\/00070\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/50006\/2013"],"award-info":[{"award-number":["UID\/QUI\/50006\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/72851\/2010"],"award-info":[{"award-number":["SFRH\/BD\/72851\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/QEQ-MED\/1890\/2014"],"award-info":[{"award-number":["PTDC\/QEQ-MED\/1890\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167218","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T15:16:17Z","timestamp":1479914177000},"page":"e0167218","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent"],"prefix":"10.1371","volume":"11","author":[{"given":"Ana L. M.","family":"Batista de Carvalho","sequence":"first","affiliation":[]},{"given":"Paula S. C.","family":"Medeiros","sequence":"additional","affiliation":[]},{"given":"Francisco M.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Vanessa P.","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Joana B.","family":"Sousa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-9360","authenticated-orcid":false,"given":"Carmen","family":"Diniz","sequence":"additional","affiliation":[]},{"given":"Maria P. M.","family":"Marques","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"issue":"7070","key":"ref1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a Therapeutic Target","volume":"438","author":"N Ferrara","year":"2005","journal-title":"Nature"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1158\/1078-0432.CCR-10-2515","article-title":"Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse\u2014A European Pooled Analysis","volume":"17","author":"W Janni","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast Cancer Metastasis: Markers and Models","volume":"5","author":"B Weigelt","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/107327481001700305","article-title":"A review of triple-negative breast cancer","volume":"17","author":"R Ismail-Khan","year":"2010","journal-title":"Cancer Control"},{"issue":"352","key":"ref5","first-page":"1","article-title":"Circulating tumour cells in breast cancer","volume":"7","author":"N Krawczyk","year":"2013","journal-title":"Ecancermedicalscience"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode","volume":"205","author":"B Rosenberg","year":"1965","journal-title":"Nature"},{"issue":"5191","key":"ref7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum Compounds\u2014a New Class of Potent Antitumour Agents","volume":"222","author":"B Rosenber","year":"1969","journal-title":"Nature"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular Processing of Platinum Anticancer Drugs","volume":"4","author":"D Wang","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/157018006776286989","article-title":"Pt(II) vs Pd(II) polyamine complexes as new anticancer drugs: A structure-activity study","volume":"3","author":"SM Fiuza","year":"2006","journal-title":"Lett Drug Des Discov"},{"issue":"14","key":"ref10","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/jp710868p","article-title":"Use of effective core potential calculations for the conformational and vibrational study of platinum(II) anticancer drugs. cis-diamminedichloroplatinum(II) as a case study","volume":"112","author":"SM Fiuza","year":"2008","journal-title":"J Phys Chem A"},{"issue":"42","key":"ref11","doi-asserted-by":"crossref","first-page":"14309","DOI":"10.1039\/c0cp00957a","article-title":"Conformational and vibrational study of cis-diamminedichloropalladium(II)","volume":"12","author":"SM Fiuza","year":"2010","journal-title":"Phys Chem Chem Phys"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1747-0285.2011.01081.x","article-title":"Biologic Activity of a Dinuclear Pd(II)-spermine Complex Toward Human Breast Cancer","volume":"77","author":"SM Fiuza","year":"2011","journal-title":"Chem Biol Drug Des"},{"key":"ref13","first-page":"29","article-title":"Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor","volume":"2013","author":"MPM Marques","year":"2013","journal-title":"ISRN Spectrosc"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.poly.2014.03.049","article-title":"Palladium(II) and platinum(II) oxamate complexes as potential anticancer agents: Structural characterization and cytotoxic activity","volume":"76","author":"WXC Oliveira","year":"2014","journal-title":"Polyhedron"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1039\/C4CS00063C","article-title":"Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes","volume":"43","author":"AR Kapdi","year":"2014","journal-title":"Chem Soc Rev"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CAD.0000000000000174","article-title":"Cytotoxic activity of novel palladium-based compounds on leukemia cell lines","volume":"26","author":"M Antunovic","year":"2015","journal-title":"Anti-Cancer Drugs"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/annonc\/mds603","article-title":"Docetaxel-cisplatin might be Superior to Docetaxel-capecitabine in the First-line Treatment of Metastatic Triple-negative Breast Cancer","volume":"24","author":"Y Fan","year":"2013","journal-title":"Ann Oncol"},{"issue":"12","key":"ref18","first-page":"5501","article-title":"Bevacizumab Plus Docetaxel and Cisplatin for Metastatic Breast Cancer: A Pilot Phase II Study","volume":"32","author":"CJ Tai","year":"2012","journal-title":"Anticancer Res"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/(SICI)1522-2675(19990707)82:7<1025::AID-HLCA1025>3.0.CO;2-1","article-title":"Palladium(II) and Platinum(II) Polyamine Complexes: X-Ray Crystal Structures of (<italic>SP<\/italic>-4-2)-Chloro{<italic>N<\/italic>-[(3-amino-<italic>\u03baN<\/italic>)propyl]propane-1,3-diamine-<italic>\u03baN<\/italic>,<italic>\u03baN<\/italic>\u2032}palladium(1+) Tetrachloropalladate (2\u2013) (2 : 1) and (<italic>R<\/italic>,<italic>S<\/italic>)-Tetrachloro[\u03bc-(spermine)]dipalladium(II) (= {\u03bc-{<italic>N<\/italic>,<italic>N<\/italic>\u2032-Bis[(3-amino-<italic>\u03baN<\/italic>)propyl]butane-1,4-diamine-<italic>\u03baN<\/italic>:<italic>\u03baN<\/italic>\u2032}}tetrachlorodipalladium)","volume":"82","author":"G Codina","year":"1999","journal-title":"Helv Chim Acta"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1039\/C5NJ01088H","article-title":"Conformational Insights and Vibrational Study of a Promising Anticancer Agent: the Role of the Ligand in Pd(II)-amine Complexes","volume":"39","author":"SM Fiuza","year":"2015","journal-title":"New J Chem"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0026-2862(89)90022-8","article-title":"Mapping of the microcirculation in the chick chorioallantoic membrane during normal angiogenesis","volume":"38","author":"DO DeFouw","year":"1989","journal-title":"Microvasc Res"},{"issue":"2","key":"ref22","first-page":"155","article-title":"Observations on the Use of the Avian Chorioallantoic Membrane (CAM) Model in Investigations into Angiogenesis","volume":"3","author":"M Richardson","year":"2003","journal-title":"Curr Drug Targets"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.3390\/ijms13089959","article-title":"Chick Chorioallantoic Membrane (CAM) Assay as an <italic>in vivo<\/italic> Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis","volume":"13","author":"NA Lokman","year":"2012","journal-title":"Int J Mol Sci"},{"key":"ref24","first-page":"47","article-title":"Cardiovascular Development","author":"D Ribatti","year":"2012"},{"key":"ref25","unstructured":"Carpentier G, Martinelli M, Courty J, Cascone I, editors. Angiogenesis Analyzer for ImageJ. 4th ImageJ. User and Developer Conference proceedings; 2012; Mondorf-les-Bains, Luxembourg."},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/carcin\/bgp292","article-title":"Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling","volume":"31","author":"J Lu","year":"2010","journal-title":"Carcinogenesis"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mrrev.2012.08.001","article-title":"<italic>In vitro<\/italic> Cell Migration and Invasion Assays","volume":"752","author":"N Kramer","year":"2013","journal-title":"Mutat Res-Rev Mutat Res"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-1759(97)00137-3","article-title":"Optimization of the Sulforhodamine B Colorimetric Assay","volume":"208","author":"KT Papazisis","year":"1997","journal-title":"J Immunol Methods"},{"issue":"16","key":"ref29","first-page":"4558","article-title":"Application of a New Approach for the Quantitation of Drug Synergism to the Combination of Cis-Diamminedichloroplatinum and 1-Beta-D-Arabinofuranosylcytosine","volume":"52","author":"MC Berenbaum","year":"1992","journal-title":"Cancer Res"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for Accurate EC50\/IC50 Estimation","volume":"10","author":"JL Sebaugh","year":"2011","journal-title":"Pharm Stat"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.193474","article-title":"Revisiting the Isobole and Related Quantitative Methods for Assessing Drug Synergism","volume":"342","author":"RJ Tallarida","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.lungcan.2015.08.003","article-title":"Anti-Angiogenic-Apecific Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Nintedanib and Docetaxel","volume":"90","author":"M Reck","year":"2015","journal-title":"Lung Cancer"},{"issue":"Suppl 2","key":"ref33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1634\/theoncologist.9-suppl_2-24","article-title":"Docetaxel and Paclitaxel in the Treatment of Breast Cancer: a Review of Clinical Experience","volume":"9","author":"J Crown","year":"2004","journal-title":"Oncologist"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12010-014-1125-6","article-title":"Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine","volume":"174","author":"P Ghanbari","year":"2014","journal-title":"Appl Biochem Biotech"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/sj.bjc.6602797","article-title":"A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points","volume":"93","author":"A O'Donnell","year":"2005","journal-title":"Br J Cancer"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jjco\/hyi229","article-title":"A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma","volume":"36","author":"PM Hoff","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000324751","article-title":"Role of the Cytoskeleton in Formation and Maintenance of Angiogenic Sprouts","volume":"48","author":"KJ Bayless","year":"2011","journal-title":"J Vasc Res"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2174\/187152012803529682","article-title":"Anti-metastatic and anti-angiogenic properties of potential new anti-cancer drugs based on metal complexes of selenosemicarbazones","volume":"12","author":"M Zec","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"issue":"7347","key":"ref39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"P Carmeliet","year":"2011","journal-title":"Nature"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbcan.2014.05.002","article-title":"Angiogenic Factors as Potential Drug Target: Efficacy and Limitations of Anti-angiogenic Therapy","volume":"1846","author":"RN Gacche","year":"2014","journal-title":"Biochim Biophys Acta-Rev Cancer"},{"issue":"0","key":"ref41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1039\/C5FD00148J","article-title":"Chemotherapeutic Response to Cisplatin-like Drugs in Human Breast Cancer Cells Probed by Vibrational Microspectroscopy","volume":"187","author":"ALM Batista de Carvalho","year":"2016","journal-title":"Farad Discuss"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/ic402796k","article-title":"DNA Condensing Effects and Sequence Selectivity of DNA Binding of Antitumor Noncovalent Polynuclear Platinum Complexes","volume":"53","author":"J Malina","year":"2014","journal-title":"Inorg Chem"},{"issue":"Suppl 7","key":"ref43","first-page":"27","article-title":"Docetaxel Plus Cisplatin: An Active Combination Regimen in Non-Small-Cell Lung Cancer","volume":"11","author":"RJ Gralla","year":"1997","journal-title":"Oncology"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1008342013224","article-title":"Docetaxel (Taxotere\u00ae)-cisplatin (TC): An effective drug combination in gastric carcinoma","volume":"11","author":"AD Roth","year":"2000","journal-title":"Ann Oncol"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1039\/C4CP05183A","article-title":"A Molecular View of Cisplatin&apos;s Mode of Action: Interplay with DNA Bases and Acquired Resistance","volume":"17","author":"MPM Marques","year":"2015","journal-title":"Phys Chem Chem Phys"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr2642","article-title":"Antiangiogenic Therapy for Beast Cancer","volume":"12","author":"DL Nielsen","year":"2010","journal-title":"Breast Cancer Res"},{"key":"ref47","first-page":"31","article-title":"Vascular Endothelial Growth Factor Modulates Cisplatin Sensitivity in Human Ovarian Carcinoma Cells","volume":"1","author":"G Hu","year":"2003","journal-title":"Cancer Therapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T18:30:55Z","timestamp":1568572255000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167218"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167218","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]}}}